Episurf Medical AB
STO:EPIS B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Episurf Medical AB
STO:EPIS B
|
SE |
|
Santos Ltd
ASX:STO
|
AU |
|
Bank Aladin Syariah Tbk PT
IDX:BANK
|
ID |
|
Synergie SE
PAR:SDG
|
FR |
|
Exchange Income Corp
TSX:EIF
|
CA |
|
P
|
Pressure Technologies PLC
LSE:PRES
|
UK |
|
Sandvik AB
STO:SAND
|
SE |
|
C
|
Castellum Inc
AMEX:CTM
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EPIS B's stock price target?
Not Available
EPIS B doesn't have any price targets made by Wall Street professionals.
What is Episurf Medical AB's Revenue forecast?
Projected CAGR
124%
For the last 9 years the
compound annual growth rate for
Episurf Medical AB's revenue is
22%.
The projected
CAGR
for the next 2 years is
124%.